Company Filing History:
3 out of 1,248 
1 out of 2,945 
Years Active: 2010-2014
Title: Annick Arbellot De Vacqueur: Innovator in Pharmaceutical Chemistry
Introduction
Annick Arbellot De Vacqueur is a prominent inventor based in Fontenay Les Briis, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target insulin resistance. With a total of 4 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest patents are innovative compounds such as imidazole derivatives that serve as fructose-1,6-bisphosphatase inhibitors. These compounds are detailed in her patent titled "Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them." Another notable patent is "Imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same." This invention relates to compounds that are crucial for treating pathologies associated with insulin resistance syndrome.
Career Highlights
Throughout her career, Annick has worked with reputable organizations, including Merck Patent Gesellschaft Mit Beschränkter Haftung and Merck Patent Gesellschaft MIT Beschrankter Haftung. Her expertise in pharmaceutical chemistry has positioned her as a key player in the development of therapeutic solutions.
Collaborations
Annick has collaborated with esteemed colleagues such as Gérard Moinet and Gérard Botton, contributing to the advancement of her research and innovations.
Conclusion
Annick Arbellot De Vacqueur's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to impact the treatment of insulin resistance and related health issues.